Price $63.10 |
Market Cap
935.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
48.4
|
P/B
4.34
|
P/S
1.75
|
Dividend %
-
|
|
P/CF
15.3
|
P/FCF
10.1
|
Op. Cash Flow
84.3K
|
FCF
6.9
|
|
Op. Margin
5.40%
|
Net Margin
3.40%
|
ROE
8.80%
|
ROI
8.70%
|
|
ROA
5.50%
|
EPS Growth
-2.60%
|
Current Ratio
2.9
|
Debt/Equity
22.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Altimmune Inc (ALT) | $3.85 | - | - | 17.4M | Strong Buy |
| Vaxart Inc (VXRT) | $3.88 | - | - | 20.3M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $5.52 | - | - | 91.9M | Strong Buy |
| Procyon Corp (PCYN) | $0.29 | - | - | 2.3M | Strong Buy |
| Civitas Solutions Inc (CIVI) | $15.46 | - | - | 527.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
